AABB launched a new website to inform the public, blood collectors and clinicians about COVID-19 convalescent plasma. The website provides information to connect people who have recovered from COVID-19 to AABB-accredited blood centers so that they can potentially donate convalescent plasma to help improve the status of critically ill patients with COVID-19. AABB yesterday also sent a letter to its member hospitals encouraging them to collaborate with their blood supplier by identifying and referring individuals who have recovered from COVID-19 for donation of COVID-19 convalescent plasma. The Food and Drug Administration, which considers COVID-19 convalescent plasma an investigational treatment, recently announced new guidelines permitting its use for patients with moderate or severe COVID-19 infections.

Related News Articles

Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…